Re: [ANN] Embleema, the patient blockchain | Product ready✅/Big Pharma Partnerships✅
Here is a short interview made during the Embleema's ICO launch night in Paris few weeks ago with :
Bernard HAMELIN, Global Head of Medical Evidence Generation @ SANOFI S.A
Sanofi S.A. is a French multinational pharmaceutical
company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales.
The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product
of several previous mergers. It changed its name to Sanofi in May 2011.
The company is a component of the Euro Stoxx 50 stock market index, and generating 33.821 billion USD$ in 2016
Bernard HAMELIN, Global Head of Medical Evidence Generation @ SANOFI S.A
Sanofi S.A. is a French multinational pharmaceutical
company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales.
The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product
of several previous mergers. It changed its name to Sanofi in May 2011.
The company is a component of the Euro Stoxx 50 stock market index, and generating 33.821 billion USD$ in 2016
